查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1871833

電漿醫學市場報告：趨勢、預測和競爭分析（至2031年）

Plasma Medicine Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

由於生物淨化、治療應用及其他市場領域的巨大機會，全球電漿醫學市場前景廣闊。預計2025年至2031年，全球電漿醫學市場將以15.2%的年複合成長率成長。推動該市場成長的關鍵因素包括：創傷治療和癌症治療領域對非侵入性治療方法的需求不斷成長、對感染控制和生物淨化方法的日益重視，以及個人化醫療的發展趨勢。

  • 根據 Lucintel 的預測，感應耦合放電法在預測期內有望達到最高的成長率。
  • 從應用領域來看，治療性應用預計將呈現最高的成長率。
  • 從區域來看，預計亞太地區在預測期內將達到最高的成長率。

電漿醫學市場的新趨勢

電漿醫學市場正經歷變革，多種新興趨勢重塑其應用領域和成長潛力。主要趨勢包括：將基於血漿的技術融入主流醫學、更加重視非侵入性治療、個人化醫療的興起、血漿滅菌技術的進步以及研究和臨床試驗的增加。

  • 非侵入性治療方法：電漿醫學因其非侵入性特性而備受關注，尤其是在創傷治療和皮膚病學領域。基於血漿的治療方法目的是無需手術干預即可治療疾病。這一趨勢改變患者照護，提高治療可及性並縮短康復時間。血漿技術的非侵入性特性推動全球基於血漿的醫療設備的日益普及。
  • 等離子滅菌技術的進步：基於血漿的滅菌技術在醫療領域，尤其是在手術器械和醫院環境的滅菌方面，正變得越來越普及。與傳統方法相比，血漿滅菌具有更有效率、更環保的優勢。它代表了醫學和公共衛生領域的重要發展趨勢，有望降低感染風險、減少醫療相關成本並改善患者的整體治療效果。
  • 以血漿為基礎的癌症療法：電漿醫學正拓展至腫瘤學領域，利用血漿治療癌細胞已成為研究熱點。研究表明，血漿可以誘導癌細胞凋亡（細胞死亡），使其成為一種極具前景的非侵入性癌症治療方法。進行中的臨床試驗和實驗研究正為基於血漿的癌症療法鋪平道路，這一新興趨勢未來或將徹底改變癌症治療模式。
  • 個人化血漿療法：個人化醫療的趨勢推動血漿療法的發展，使其能夠根據患者的特定需求量身定做治療方案。血漿療法可以根據不同的皮膚類型、傷口狀況和疾病進行個人化客製化，改善治療效果。隨著研究的深入，血漿療法將持續改進以滿足患者的獨特需求，進一步提升治療效果和患者滿意度。
  • 研發投入增加和臨床試驗增加：研發投入的不斷成長以及臨床試驗數量的增加推動血漿療法的發展。研究機構、醫院和製藥公司都在加大研究投入，以便更佳了解血漿的作用機制及其多樣化的應用。臨床試驗數量的增加有望促進血漿療法產品的創新和商業化，推動市場成長。

這些新興趨勢顯著改變電漿醫學市場。血漿療法的非侵入性提升了患者體驗，而血漿滅菌技術和癌症治療的進步對整個醫療保健領域產生深遠影響。個人化醫療和臨床試驗的增加將進一步推動創新和應用，重塑市場格局，並促進血漿治療方法的更廣泛接受和使用。

電漿醫學市場的最新趨勢

在技術創新、新研究成果和監管核准的推動下，電漿醫學市場正經歷顯著發展。關鍵進展包括基於血漿的醫療設備的推出、血漿在癌症治療中日益廣泛的應用，以及醫療機構和學術機構之間研究合作的加強。未來，技術進步、監管支持以及對血漿治療潛力的持續研究將共同塑造市場的未來成長。

  • 美國食品藥物管理局（FDA）核准電漿醫學設備：美國食品藥物管理局（FDA）核准電漿醫學設備是市場上的重大進展。用於創傷治療、皮膚治療和消毒的器械現在更容易被醫療保健提供者使用。這項監管核准為血漿技術在臨床環境中更廣泛的應用鋪平了道路，加速了血漿醫學的發展。
  • 血漿癌症療法取得突破：基於血漿的癌症療法取得了顯著進展，研究表明其在誘導癌細胞死亡方面具有令人鼓舞的成果。血漿能夠以非侵入性的方式靶向和治療腫瘤，這一特性引起了廣泛關注，目前進行中的臨床試驗檢驗其對多種癌症類型的療效。如果成功，血漿癌症療法治療方法成為腫瘤學領域的突破，為患者提供新的治療選擇。
  • 新型電漿醫學設備的研發：許多公司研發新型、更有效率的電漿醫學設備，其應用範圍廣泛，涵蓋創傷治療到牙科治療等領域。這些設備目的是提供更快、更有效的治療，改善患者預後並降低醫療成本。這項研發成果正推動血漿療法在全球醫療機構的應用。
  • 醫療機構與研究機構之間的合作：醫療機構與研究機構之間合作的加強加速血漿療法的發展。這些合作對於推動新型血漿治療方法的研發、擴大臨床試驗規模、提升電漿醫學技術非常重要。這些夥伴關係有助於將血漿療法融入現有的醫療保健體系，為市場成長奠定堅實的基礎。
  • 血漿在滅菌和感染控制中的應用：基於血漿的滅菌技術在醫療保健和醫院環境中日益普及。血漿能夠對醫療器材、物體表面甚至空氣進行滅菌，使其成為醫療機構中有效的感染控制手段。鑑於醫療相關感染仍然是一個重大問題，血漿滅菌解決方案正成為傳統方法的一種極具前景的替代方案。

近期的這些進展鞏固了血漿療法作為一種實用有效的治療選擇在醫療保健領域的地位。 FDA的核准、癌症治療的進步、新型醫療設備的研發以及合作的加強，都在推動市場成長和應用。隨著血漿療法的不斷發展，其在各個醫學領域的治療潛力將不斷擴大，帶來更多臨床應用和更大的市場佔有率。

目錄

第1章 執行摘要

第2章 市場概覽

  • 背景和分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球電漿醫學市場（依類型）

  • 吸引力分析：依類型
  • 電容耦合放電
  • 感應耦合放電
  • 等離子射流

第5章 全球電漿醫學市場（依應用領域）

  • 吸引力分析：依應用
  • 生物淨化
  • 治療用途
  • 其他

第6章 區域分析

第7章 北美電漿醫學市場

  • 北美醫用血漿市場：依類型
  • 北美醫用血漿市場：依應用
  • 美國電漿醫學市場
  • 墨西哥電漿醫學市場
  • 加拿大電漿醫學市場

第8章 歐洲電漿醫學市場

  • 歐洲醫用血漿市場：依類型
  • 歐洲醫用血漿市場：依應用
  • 德國醫用血漿市場
  • 法國醫用血漿市場
  • 西班牙電漿醫學市場
  • 義大利電漿醫學市場
  • 英國電漿醫學市場

第9章 亞太地區電漿醫學市場

  • 亞太地區電漿醫學市場：依類型
  • 亞太地區電漿醫學市場：依應用
  • 日本電漿醫學市場
  • 印度電漿醫學市場
  • 中國電漿醫學市場
  • 韓國電漿醫學市場
  • 印尼電漿醫學市場

第10章 世界其他地區（ROW）電漿醫學市場

  • ROW 電漿醫學市場：依類型
  • ROW 電漿醫學市場：依應用
  • 中東電漿醫學市場
  • 南美洲電漿醫學市場
  • 非洲電漿醫學市場

第11章 競爭分析

  • 產品系列分析
  • 運作整合
  • 波特五力分析
  • 市場佔有率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 全球電漿醫學市場的新趨勢
  • 戰略分析

第13章 價值鏈中主要企業的概況

  • 競爭分析
  • US Medical Innovations
  • Plasmacure
  • Neoplas Med GMBH
  • Plasma Surgical
  • Cold Plasmatech GMBH

第14章 附錄

The future of the global plasma medicine market looks promising with opportunities in the biological decontamination, therapeutic applications, and others markets. The global plasma medicine market is expected to grow with a CAGR of 15.2% from 2025 to 2031. The major drivers for this market are the rising demand for non-invasive treatments in wound healing and cancer., the increasing focus on infection control and biological decontamination methods., and the trend toward personalized medicine.

  • Lucintel forecasts that, within the type category, inductively coupled discharges is expected to witness the highest growth over the forecast period.
  • Within the application category, therapeutic applications is expected to witness the highest growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Plasma Medicine Market

The plasma medicine market is evolving with several emerging trends that are reshaping its applications and growth potential. Key trends include the integration of plasma-based technologies into mainstream healthcare, increasing focus on non-invasive treatments, the rise of personalized medicine, advancements in plasma sterilization techniques, and the growing number of research and clinical trials.

  • Non-Invasive Treatments and Therapeutics: Plasma medicine is gaining attention for its non-invasive nature, particularly in wound healing and dermatology. Plasma-based therapies are being designed to treat conditions without the need for surgical intervention. This trend is reshaping patient care, making treatments more accessible and reducing recovery times. The non-invasive nature of plasma technologies is contributing to the growing adoption of plasma-based medical devices globally.
  • Advancements in Plasma Sterilization: Plasma-based sterilization technologies are becoming increasingly popular in the medical field, especially for sterilizing surgical tools and hospital environments. Plasma sterilization offers advantages over traditional methods by being more efficient and environmentally friendly. It has the potential to reduce the risk of infection, lower healthcare-associated costs, and improve overall patient outcomes, making it a key trend in healthcare and public health.
  • Plasma-based Cancer Treatments: Plasma medicine is expanding into oncology, with research focusing on the use of plasma to treat cancer cells. Studies suggest that plasma can induce apoptosis in cancer cells, offering a promising non-invasive alternative to traditional cancer treatments. Ongoing clinical trials and experimental studies are paving the way for plasma-based cancer therapies, and this emerging trend could revolutionize cancer care in the future.
  • Personalized Plasma Medicine: The trend toward personalized medicine is influencing the development of plasma therapies, where treatments are tailored to the individual's specific needs. Plasma medicine can be customized for different skin types, wound conditions, or diseases, improving the effectiveness of the therapy. As research progresses, plasma therapies will be increasingly adapted to meet the unique requirements of patients, enhancing patient outcomes and satisfaction.
  • Increased R&D and Clinical Trials: The growing investment in research and development, coupled with an increasing number of clinical trials, is accelerating the growth of plasma medicine. Research institutions, hospitals, and pharmaceutical companies are investing in studies to better understand the mechanisms of plasma and its diverse applications. The increasing number of clinical trials is likely to drive innovation and the commercialization of plasma-based medical products, boosting market growth.

These emerging trends are significantly transforming the plasma medicine market. The non-invasive nature of plasma treatments is enhancing patient experience, while advancements in plasma sterilization and cancer treatment have broad implications for the medical field. Personalized medicine and the rise in clinical trials will further accelerate innovation and adoption, reshaping the market landscape and contributing to broader acceptance and usage of plasma-based therapies.

Recent Developments in the Plasma Medicine Market

The plasma medicine market is seeing significant advancements, driven by innovations in technology, new research findings, and regulatory approvals. Key developments include the introduction of plasma-based medical devices, advancements in plasma applications for cancer treatment, and increasing research collaborations between healthcare providers and academic institutions. The market's future growth will be shaped by technological progress, regulatory support, and continued research into plasma's therapeutic potential.

  • FDA Approvals for Plasma Medical Devices: The approval of plasma-based medical devices by the U.S. Food and Drug Administration (FDA) has been a major development in the market. Devices for wound healing, dermatological treatments, and sterilization are now more accessible to healthcare providers. This regulatory validation has opened the door for wider adoption of plasma technologies in the clinical setting, accelerating the growth of plasma medicine.
  • Breakthroughs in Plasma Cancer Therapy: Significant breakthroughs have been made in plasma-based cancer treatments, with research showing promising results in inducing cancer cell death. Plasma's ability to target and treat tumors non-invasively is gaining attention, and ongoing clinical trials are exploring its efficacy in various cancer types. If successful, plasma cancer therapy could become a game-changer in oncology, offering patients a new avenue of treatment.
  • Development of New Plasma Medical Devices: Several companies are developing new, more efficient plasma medical devices for applications ranging from wound healing to dental care. These devices are designed to provide quicker and more effective treatments, improving patient outcomes and reducing healthcare costs. The development of these devices is contributing to the growing adoption of plasma medicine in medical practices worldwide.
  • Collaboration Between Healthcare and Research Institutions: Increasing collaboration between medical institutions and research organizations is accelerating the development of plasma therapies. These collaborations are essential for driving forward new plasma-based treatment modalities, expanding clinical trials, and refining the technology behind plasma medicine. These partnerships are helping to integrate plasma medicine into existing healthcare systems and establishing a strong foundation for market growth.
  • Plasma for Sterilization and Infection Control: Plasma-based sterilization technologies are gaining recognition in medical and hospital environments. Plasma can sterilize surgical instruments, surfaces, and even air, making it an effective tool for infection control in healthcare settings. As healthcare-associated infections continue to be a significant concern, plasma sterilization solutions are emerging as a promising alternative to traditional methods.

These recent developments are helping to solidify plasma medicine's position as a viable and effective treatment option in the healthcare industry. FDA approvals, advances in cancer therapy, new device developments, and increased collaboration are accelerating market growth and adoption. As plasma medicine continues to evolve, its therapeutic potential across various medical fields is expected to expand, resulting in greater clinical applications and a larger market share.

Strategic Growth Opportunities in the Plasma Medicine Market

The plasma medicine market presents numerous growth opportunities across various medical applications. These opportunities are driven by technological innovations, increasing demand for non-invasive treatments, and advancements in clinical research. The key areas for growth include wound healing, cancer treatment, dental care, sterilization, and regenerative medicine.

  • Wound Healing Applications: Plasma medicine offers significant growth potential in the wound healing market. Plasma-based therapies can speed up the healing of chronic and diabetic wounds, making them a promising option for patients with slow-healing conditions. As demand for non-invasive wound healing treatments rises, plasma technology is poised to become a key player in this field, expanding its market share.
  • Cancer Treatment Advancements: Plasma's potential in cancer treatment is driving growth in the oncology segment. Studies suggest that plasma can selectively target cancer cells without harming healthy tissue, offering a non-invasive alternative to traditional cancer therapies. As research continues, plasma-based cancer treatments could provide new options for patients and revolutionize cancer care.
  • Dental Applications: Plasma medicine is gaining popularity in the dental industry for applications such as sterilization, root canal treatments, and oral infections. Plasma-based therapies offer effective, non-invasive solutions for dental care, reducing recovery times and improving patient comfort. The growing focus on non-invasive dental treatments is expected to drive significant market growth in this sector.
  • Sterilization and Infection Control: Plasma technology's ability to sterilize medical equipment, hospital surfaces, and even air offers substantial growth opportunities in infection control. As hospitals and healthcare providers focus on reducing healthcare-associated infections, plasma-based sterilization solutions are expected to become a critical component in infection prevention strategies, fostering growth in this segment.
  • Regenerative Medicine: Plasma's potential in regenerative medicine, particularly in tissue repair and skin regeneration, represents a promising area for growth. Plasma is being investigated for its ability to stimulate tissue regeneration, offering a non-invasive alternative for patients with injuries or degenerative conditions. Continued research and innovation in regenerative medicine will likely drive further market expansion.

These growth opportunities are contributing to the expansion of the plasma medicine market. As plasma technologies are increasingly adopted in wound healing, cancer treatment, dental care, sterilization, and regenerative medicine, the market is set to experience significant growth. These applications, coupled with ongoing research and innovation, will reshape the landscape of the plasma medicine market, unlocking new revenue streams and fostering widespread adoption.

Plasma Medicine Market Driver and Challenges

The growth of the plasma medicine market is influenced by a variety of technological, economic, and regulatory factors. Key drivers include advancements in plasma technology, increasing demand for non-invasive therapies, and regulatory approvals. However, challenges such as high research and development costs, regulatory hurdles, and limited awareness could impact the market's growth trajectory. Addressing these issues will be crucial for maximizing the potential of plasma medicine.

The factors responsible for driving the Plasma Medicine market include:

1. Technological Advancements: Continuous advancements in plasma generation technology, device development, and therapeutic applications are driving market growth. These innovations are making plasma medicine more effective, efficient, and accessible across various medical fields.

2. Increasing Demand for Non-Invasive Treatments: The growing preference for non-invasive therapies in areas like wound healing, dermatology, and cancer treatment is driving the adoption of plasma-based solutions, improving patient outcomes and satisfaction.

3. Regulatory Support and Approvals: The increasing number of regulatory approvals for plasma-based medical devices and therapies is fostering confidence in the market. This approval process is unlocking new opportunities for market players and healthcare providers.

4. Rising Healthcare Costs and Focus on Efficiency: Plasma medicine's cost-effectiveness and ability to streamline treatment processes are appealing to healthcare providers looking for more efficient solutions, especially in the context of rising healthcare costs.

5. Rising Incidence of Chronic Diseases: The growing prevalence of chronic diseases like diabetes, which often lead to chronic wounds, is fueling demand for plasma-based wound healing and regeneration therapies.

Challenges in the Plasma Medicine market are:

1. High Research and Development Costs: The significant costs associated with plasma medicine research and development can hinder the pace of innovation and the widespread adoption of plasma therapies.

2. Regulatory Barriers and Delays: While regulatory approvals are essential for market growth, lengthy approval processes, particularly for new plasma-based therapies, can delay commercialization and market penetration.

3. Limited Public Awareness: Plasma medicine is still relatively new, and limited awareness among healthcare providers and patients can slow down adoption. Education and awareness initiatives will be vital for market growth.

The plasma medicine market is growing rapidly, driven by technological advancements, regulatory support, and the increasing demand for non-invasive therapies. However, high R&D costs, regulatory hurdles, and limited awareness remain challenges that need to be addressed. Overcoming these obstacles will be key to unlocking the full potential of plasma medicine and facilitating its adoption across various medical fields.

List of Plasma Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies plasma medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the plasma medicine companies profiled in this report include-

  • US Medical Innovations
  • Plasmacure
  • Neoplas Med GMBH
  • Plasma Surgical
  • Cold Plasmatech GMBH

Plasma Medicine Market by Segment

The study includes a forecast for the global plasma medicine market by type, application, and region.

Plasma Medicine Market by Type [Value from 2019 to 2031]:

  • Capacitively Coupled Discharges
  • Inductively Coupled Discharges
  • Plasma Jets

Plasma Medicine Market by Application [Value from 2019 to 2031]:

  • Biological Decontamination
  • Therapeutic Applications
  • Others

Plasma Medicine Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Plasma Medicine Market

The plasma medicine market is gaining significant momentum, driven by advancements in medical technologies, growing interest in non-invasive treatments, and applications across various therapeutic fields such as dermatology, oncology, and wound healing. Key countries like the United States, China, Germany, India, and Japan are making significant strides in the development, approval, and adoption of plasma-based therapies. This market is expected to expand rapidly as plasma technology continues to show promising clinical applications.

  • United States: In the United States, plasma medicine is gaining traction, particularly in dermatology and wound healing. Recent developments include FDA-approved plasma-based medical devices and innovations in plasma-based cancer treatment. American research institutions are exploring plasma's potential in treating skin conditions, infections, and promoting tissue regeneration. With growing investment in R&D and clinical trials, the U.S. is positioning itself as a leader in plasma medicine commercialization and adoption.
  • China: China is rapidly adopting plasma medicine, with advancements being made in the use of plasma for wound care, dermatology, and oral health. The government has supported research into plasma applications in medical treatments, and the increasing demand for non-invasive therapies is pushing plasma-based solutions forward. Chinese manufacturers are innovating and producing affordable plasma medical devices, contributing to the broader availability of plasma medicine in healthcare settings.
  • Germany: Germany stands out as a European leader in plasma medicine, with key research initiatives aimed at integrating plasma technologies into clinical treatments for cancer, skin conditions, and chronic wounds. The country has invested heavily in both fundamental and applied research to expand plasma-based therapies. German companies are at the forefront of developing and commercializing plasma medical devices, helping establish Germany as a central hub for plasma medicine in Europe.
  • India: India's plasma medicine market is expanding, particularly in the areas of wound healing, dental care, and skin treatment. The rising demand for cost-effective, non-invasive treatments is driving the market's growth. Indian researchers and clinicians are increasingly exploring the therapeutic potential of plasma, with more clinical trials underway. Though adoption is still in its early stages, there is significant potential for growth in the coming years, especially in underserved regions.
  • Japan: Japan is making notable progress in the use of plasma medicine, with a strong focus on wound healing, sterilization, and skin treatments. Plasma-based technologies are being increasingly integrated into medical devices, and Japanese companies are leading the development of equipment for plasma therapy. Research institutions are also conducting trials to explore plasma's potential in oncology and regenerative medicine, positioning Japan as a key player in the Asian plasma medicine market.

Features of the Global Plasma Medicine Market

  • Market Size Estimates: Plasma medicine market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2023) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Plasma medicine market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Plasma medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the plasma medicine market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the plasma medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the plasma medicine market by type (capacitively coupled discharges, inductively coupled discharges, and plasma jets), application (biological decontamination, therapeutic applications, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Plasma Medicine Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Capacitively Coupled Discharges: Trends and Forecast (2019-2031)
  • 4.4 Inductively Coupled Discharges: Trends and Forecast (2019-2031)
  • 4.5 Plasma Jets: Trends and Forecast (2019-2031)

5. Global Plasma Medicine Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Biological Decontamination: Trends and Forecast (2019-2031)
  • 5.4 Therapeutic Applications: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Plasma Medicine Market by Region

7. North American Plasma Medicine Market

  • 7.1 Overview
  • 7.2 North American Plasma Medicine Market by type
  • 7.3 North American Plasma Medicine Market by application
  • 7.4 United States Plasma Medicine Market
  • 7.5 Mexican Plasma Medicine Market
  • 7.6 Canadian Plasma Medicine Market

8. European Plasma Medicine Market

  • 8.1 Overview
  • 8.2 European Plasma Medicine Market by type
  • 8.3 European Plasma Medicine Market by application
  • 8.4 German Plasma Medicine Market
  • 8.5 French Plasma Medicine Market
  • 8.6 Spanish Plasma Medicine Market
  • 8.7 Italian Plasma Medicine Market
  • 8.8 United Kingdom Plasma Medicine Market

9. APAC Plasma Medicine Market

  • 9.1 Overview
  • 9.2 APAC Plasma Medicine Market by type
  • 9.3 APAC Plasma Medicine Market by application
  • 9.4 Japanese Plasma Medicine Market
  • 9.5 Indian Plasma Medicine Market
  • 9.6 Chinese Plasma Medicine Market
  • 9.7 South Korean Plasma Medicine Market
  • 9.8 Indonesian Plasma Medicine Market

10. ROW Plasma Medicine Market

  • 10.1 Overview
  • 10.2 ROW Plasma Medicine Market by type
  • 10.3 ROW Plasma Medicine Market by application
  • 10.4 Middle Eastern Plasma Medicine Market
  • 10.5 South American Plasma Medicine Market
  • 10.6 African Plasma Medicine Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Plasma Medicine Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 US Medical Innovations
    • Company Overview
    • Plasma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Plasmacure
    • Company Overview
    • Plasma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Neoplas Med GMBH
    • Company Overview
    • Plasma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Plasma Surgical
    • Company Overview
    • Plasma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Cold Plasmatech GMBH
    • Company Overview
    • Plasma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Plasma Medicine Market
  • Figure 2.1: Usage of Plasma Medicine Market
  • Figure 2.2: Classification of the Global Plasma Medicine Market
  • Figure 2.3: Supply Chain of the Global Plasma Medicine Market
  • Figure 3.1: Driver and Challenges of the Plasma Medicine Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Plasma Medicine Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Plasma Medicine Market ($B) by Type
  • Figure 4.3: Forecast for the Global Plasma Medicine Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Capacitively Coupled Discharges in the Global Plasma Medicine Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Inductively Coupled Discharges in the Global Plasma Medicine Market (2019-2031)
  • Figure 4.6: Trends and Forecast for Plasma Jets in the Global Plasma Medicine Market (2019-2031)
  • Figure 5.1: Global Plasma Medicine Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Plasma Medicine Market ($B) by Application
  • Figure 5.3: Forecast for the Global Plasma Medicine Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Biological Decontamination in the Global Plasma Medicine Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Therapeutic Applications in the Global Plasma Medicine Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global Plasma Medicine Market (2019-2031)
  • Figure 6.1: Trends of the Global Plasma Medicine Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Plasma Medicine Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Plasma Medicine Market by type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Plasma Medicine Market ($B) by type (2019-2024)
  • Figure 7.3: Forecast for the North American Plasma Medicine Market ($B) by type (2025-2031)
  • Figure 7.4: North American Plasma Medicine Market by application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Plasma Medicine Market ($B) by application (2019-2024)
  • Figure 7.6: Forecast for the North American Plasma Medicine Market ($B) by application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Plasma Medicine Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Plasma Medicine Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Plasma Medicine Market ($B) (2019-2031)
  • Figure 8.1: European Plasma Medicine Market by type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Plasma Medicine Market ($B) by type (2019-2024)
  • Figure 8.3: Forecast for the European Plasma Medicine Market ($B) by type (2025-2031)
  • Figure 8.4: European Plasma Medicine Market by application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Plasma Medicine Market ($B) by application (2019-2024)
  • Figure 8.6: Forecast for the European Plasma Medicine Market ($B) by application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Plasma Medicine Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Plasma Medicine Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Plasma Medicine Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Plasma Medicine Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Plasma Medicine Market ($B) (2019-2031)
  • Figure 9.1: APAC Plasma Medicine Market by type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Plasma Medicine Market ($B) by type (2019-2024)
  • Figure 9.3: Forecast for the APAC Plasma Medicine Market ($B) by type (2025-2031)
  • Figure 9.4: APAC Plasma Medicine Market by application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Plasma Medicine Market ($B) by application (2019-2024)
  • Figure 9.6: Forecast for the APAC Plasma Medicine Market ($B) by application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Plasma Medicine Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Plasma Medicine Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Plasma Medicine Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Plasma Medicine Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Plasma Medicine Market ($B) (2019-2031)
  • Figure 10.1: ROW Plasma Medicine Market by type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Plasma Medicine Market ($B) by type (2019-2024)
  • Figure 10.3: Forecast for the ROW Plasma Medicine Market ($B) by type (2025-2031)
  • Figure 10.4: ROW Plasma Medicine Market by application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Plasma Medicine Market ($B) by application (2019-2024)
  • Figure 10.6: Forecast for the ROW Plasma Medicine Market ($B) by application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Plasma Medicine Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Plasma Medicine Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Plasma Medicine Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Plasma Medicine Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Plasma Medicine Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Plasma Medicine Market by Type
  • Figure 12.2: Growth Opportunities for the Global Plasma Medicine Market by Application
  • Figure 12.3: Growth Opportunities for the Global Plasma Medicine Market by Region
  • Figure 12.4: Emerging Trends in the Global Plasma Medicine Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Plasma Medicine Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Plasma Medicine Market by Region
  • Table 1.3: Global Plasma Medicine Market Parameters and Attributes
  • Table 3.1: Trends of the Global Plasma Medicine Market (2019-2024)
  • Table 3.2: Forecast for the Global Plasma Medicine Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Plasma Medicine Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Plasma Medicine Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Plasma Medicine Market (2025-2031)
  • Table 4.4: Trends of Capacitively Coupled Discharges in the Global Plasma Medicine Market (2019-2024)
  • Table 4.5: Forecast for Capacitively Coupled Discharges in the Global Plasma Medicine Market (2025-2031)
  • Table 4.6: Trends of Inductively Coupled Discharges in the Global Plasma Medicine Market (2019-2024)
  • Table 4.7: Forecast for Inductively Coupled Discharges in the Global Plasma Medicine Market (2025-2031)
  • Table 4.8: Trends of Plasma Jets in the Global Plasma Medicine Market (2019-2024)
  • Table 4.9: Forecast for Plasma Jets in the Global Plasma Medicine Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Plasma Medicine Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Plasma Medicine Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Plasma Medicine Market (2025-2031)
  • Table 5.4: Trends of Biological Decontamination in the Global Plasma Medicine Market (2019-2024)
  • Table 5.5: Forecast for Biological Decontamination in the Global Plasma Medicine Market (2025-2031)
  • Table 5.6: Trends of Therapeutic Applications in the Global Plasma Medicine Market (2019-2024)
  • Table 5.7: Forecast for Therapeutic Applications in the Global Plasma Medicine Market (2025-2031)
  • Table 5.8: Trends of Others in the Global Plasma Medicine Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global Plasma Medicine Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Plasma Medicine Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Plasma Medicine Market (2025-2031)
  • Table 7.1: Trends of the North American Plasma Medicine Market (2019-2024)
  • Table 7.2: Forecast for the North American Plasma Medicine Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various type in the North American Plasma Medicine Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various type in the North American Plasma Medicine Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various application in the North American Plasma Medicine Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various application in the North American Plasma Medicine Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Plasma Medicine Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Plasma Medicine Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Plasma Medicine Market (2019-2031)
  • Table 8.1: Trends of the European Plasma Medicine Market (2019-2024)
  • Table 8.2: Forecast for the European Plasma Medicine Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various type in the European Plasma Medicine Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various type in the European Plasma Medicine Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various application in the European Plasma Medicine Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various application in the European Plasma Medicine Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Plasma Medicine Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Plasma Medicine Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Plasma Medicine Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Plasma Medicine Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Plasma Medicine Market (2019-2031)
  • Table 9.1: Trends of the APAC Plasma Medicine Market (2019-2024)
  • Table 9.2: Forecast for the APAC Plasma Medicine Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various type in the APAC Plasma Medicine Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various type in the APAC Plasma Medicine Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various application in the APAC Plasma Medicine Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various application in the APAC Plasma Medicine Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Plasma Medicine Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Plasma Medicine Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Plasma Medicine Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Plasma Medicine Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Plasma Medicine Market (2019-2031)
  • Table 10.1: Trends of the ROW Plasma Medicine Market (2019-2024)
  • Table 10.2: Forecast for the ROW Plasma Medicine Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various type in the ROW Plasma Medicine Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various type in the ROW Plasma Medicine Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various application in the ROW Plasma Medicine Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various application in the ROW Plasma Medicine Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Plasma Medicine Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Plasma Medicine Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Plasma Medicine Market (2019-2031)
  • Table 11.1: Product Mapping of Plasma Medicine Suppliers Based on Segments
  • Table 11.2: Operational Integration of Plasma Medicine Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Plasma Medicine Revenue
  • Table 12.1: New Product Launches by Major Plasma Medicine Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Plasma Medicine Market